Peter L. Choyke, M.D., F.A.C.R.
Dr. Choyke directs the Molecular Imaging Branch. His research interests include the translation of molecular imaging methods, such as MRI, optical and radionuclide/PET into the clinic. His primary clinical focus is on imaging, diagnosis and therapy of prostate cancer. In the lab, Dr. Choyke focuses on understanding uptake of various PET agents, including PSMA, at the genomic level. In addition, his lab works on the development of new imaging methods for cancer including cell labeling with PET agents, and imaging the tumor microenvironment including immune markers.
1) prostate cancer, 2) cell tracking, 3) radiopharmaceutical development,
4) lymphatic imaging, 5) cell tracking, 6) tumor microenvironment
Contact Info
Center for Cancer Research
National Cancer Institute
Building 10, Room B3B69F
Bethesda, MD 20892-1088
Ph: 240-760-6093
pchoyke@nih.gov
-
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
Open - RecruitingNCI Protocol ID NCI-17-C-0109Investigator Peter L. Choyke, M.D., F.A.C.R. -
Evaluation of 18F-DCFPyL PSMA- versus 18F-NaF-PET imaging for Detection of Metastatic Prostate Cancer
Open - RecruitingNCI Protocol ID NCI-17-C-0089Investigator Peter L. Choyke, M.D., F.A.C.R.
The vision of the Molecular Imaging Branch is to accelerate the development of new treatments for cancer using advanced imaging methods. Dr. Choyke's research interests include the translation of molecular imaging methods, such as MRI, optical and radionuclide/PET into the clinic. His research includes novel methods of detecting ovarian cancer, prostate cancer, angiogenesis, lymphangiogenesis, cancer cell receptor imaging and treatment, cell tracking, and exploration of unique animal models of cancer.
Selected Recent Publications
- Cancer Res. 80(14): 2975-76, 2020. [ Journal Article ]
- Radiology. [Epub ahead of print - July 7], 2020. [ Journal Article ]
- Eur Urol. [Epub ahead of print - June 9], 2020. [ Journal Article ]
- J Immunother Cancer. 8(1): e000655, 2020. [ Journal Article ]
- New Engl J Med. 382(10): 917-28, 2020. [ Journal Article ]
Dr. Choyke obtained his M.D. from Jefferson Medical College and completed his residency in diagnostic radiology at Yale-New Haven Hospital. Following an imaging fellowship at the University of Pennsylvania, he joined the faculty of Georgetown University and soon thereafter the Diagnostic Radiology Department, Clinical Center, NIH. Since 2004, he has directed the Molecular Imaging Branch within the Center for Cancer Research, NCI
| Name | Position |
|---|---|
| Mona Cedo B.S., CNMT | Nuclear Medicine Technologist (Contr.) |
| Stephen S. Adler Ph.D. | Research Physicist (Contr.) |
| Fahim Ahmad Ph.D. | Postdoctoral Fellow (Visiting) |
| Ethan Bergvall M.D. | Research Collaborator |
| Jorge Carrasquillo M.D. | Special Volunteer |
| Dagane Daar M.S. RT | MRI Technician (Contr.) |
| Philip C. Eclarinal | PET Technician |
| Michael V. Green | Research Physicist (Contr.) |
| Gary Leonard Griffiths Ph.D. | Research Associate III (Contr.) |
| Stephanie Harmon | Scientist I (Contr.) |
| Paula M. Jacobs Ph.D. | Adjunct Investigator |
| Elaine M. Jagoda, M.S. | Staff Scientist |
| Karen A. Kurdziel M.D. | Assistant Research Physician |
| Christopher Leyson M.S., CNMT | Nuclear Medicine Technologist (Contr.) |
| M. Liza Lindenberg, M.D. | Associate Research Physician |
| Mirna Martinez | Clinical Coordinator (Contr.) |
| Yolanda L. McKinney B.S.N., R.N. | Clinical Research Nurse |
| Sherif Mehralivand Ph.D. | Postdoctoral Fellow (Visiting) |
| Esther Mena-Gonzalez M.D. | Assistant Research Physician |
| Colleen Olkowski B.S. | Research Associate I (Contr.) |
| Jonathan Sackett | Special Volunteer |
| Thomas Sanford M.D. | Special Volunteer |
| Noriko Sato, M.D., Ph.D. | Staff Scientist |
| Jurgen Seidel Ph.D. | Research Physicist (Contr.) |
| Hoa Tieu | MRI Technician (Contr.) |
| Anita Ton | Technician |
| Ismail Baris Turkbey, M.D. | Associate Research Physician |
| Juanita Weaver | Program Coordinator (Contr.) |
| Karen Wong M.S. | Technical Laboratory Manager |
Medical Student, Duke University Medical School
_____________________________________________________________________________________
Attending, NYU Diagnostic Radiology
_____________________________________________________________________________________
Attending, Massachusetts General Hospital, Medical Oncology
_____________________________________________________________________________________
Attending, University of Pittsburgh, Diagnostic Radiology
_____________________________________________________________________________________
Attending, Addensbrooke Hospital Cambridge UK, Radiology
_____________________________________________________________________________________
Staff Clinician, Molecular Imaging Program, NCI
_____________________________________________________________________________________
Attending, MD Anderson, Houston, Nuclear Radiology
_____________________________________________________________________________________
Staff Clinician, Molecular Imaging Program, NCI
_____________________________________________________________________________________
Resident, University of Wisconsin, Obstetrics and Gynecology
_____________________________________________________________________________________
Resident, UCLA, Diagnostic Radiology
_____________________________________________________________________________________
Attending, UCLA, Diagnostic Radiology
_____________________________________________________________________________________
Medical Director, Mid-Atlantic Permanente Medical Group
Specialty is Internal Medicine
_____________________________________________________________________________________
News
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
March 4, 2020
NCI Press Release
A method of testing for prostate cancer developed at the National Cancer Institute (NCI) leads to more accurate diagnosis and prediction of the course of the disease, according to a large study. Learn more...
Smarter Prostate Cancer Diagnosis
CCR Milestones 2020
CCR researchers have developed new artificial intelligence tools that will help radiologists improve prostate cancer diagnosis. Learn more...
Seeing Prostate Cancer More Clearly
CCR Milestones 2017
A new imaging method enables sensitive detection and monitoring of high-risk prostate cancers. Learn more...
